Top Markets
Coin of the day
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Clasificación en acciones #19061
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Precio por acción
$1.27
Capitalización bursátil
$176.31M
Cambio (1 día)
5.57%
Cambio (1 año)
29.36%
País
TW
Comercio Medigen Biotechnology Corp. (3176)

Categoría

Historial del precio de la acción de Medigen Biotechnology Corp. (3176)
Precio más alto de cierre: $1.12 el 2026-08-01

Precio más bajo de cierre: $1.26 el 2007-12-01
Historial del precio de la acción de Medigen Biotechnology Corp. desde 2007 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.89%
2025 -0.53%
2024 -32.95%
2023 27.93%
2022 -41.27%
2021 -4.41%
2020 1.18%
2019 52.77%
2018 15.52%
2017 -52.31%
2016 -10.15%
2015 -44.93%
2014 -20.99%
2013 7.34%
2012 409.30%
2011 131.95%
2010 8.02%
2009 42.20%
2008 -74.41%
2007 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$548.98 41.79%
US
$1.04K 46.43%
NL
$149.93 506.27%
US
$121.62 -12.98%
AU
$763.69 6.14%
CH